Rating History for Acadia Pharmaceuticals (ACAD) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for ACAD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/29/2026 Tazeen Ahmad Maintain Underperform
(N/A)		 14.50
(13.00)		  
 		   Details